CURI · Insider Trading

CuriosityStream Inc. Class A Common Stock

Every open-market purchase and sale reported by CURI officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
38
most recent
Open-Market Buys
5
code P
Sales
14
code S
Reporting Insiders
10
current holders
CURI — Recent Form 4 Transactions (latest 2026-09-17)
FiledInsiderRole TypeSharesValue
2026-09-17 Sean Adam Piche Chief Financial Officer A +150,000 deriv. —
2026-09-16 Sean Adam Piche Chief Financial Officer A +150,000 deriv. —
2026-09-01 Clinton Larry Stinchcomb President and CEO Buy +20,000 +$52.06K
2026-08-31 Clinton Larry Stinchcomb President and CEO Buy +30,000 +$76.59K
2026-07-30 Theresa Ellen Cudahy COO and Secretary MIXED +134,869 −$123.68K
2026-07-28 Phillip Brady Hayden Chief Financial Officer MIXED +9,664 −$18.41K
2026-07-28 Rebecca R Reed Gen Counsel MIXED +24,395 −$30.80K
2026-06-16 Patrick J. Keeley Director Sell −31,559 −$85.16K
2026-06-16 Phillip Brady Hayden Chief Financial Officer Sell −30,400 −$77.88K
2026-06-01 Clinton Larry Stinchcomb President and CEO Buy +25,744 +$71.49K
2026-05-29 Clinton Larry Stinchcomb President and CEO Buy +94,256 +$258.64K
2026-05-28 Clinton Larry Stinchcomb President and CEO Buy +30,000 +$80.04K
2026-03-13 Clinton Larry Stinchcomb President and CEO MIXED +403,262 −$643.33K
2026-02-12 Phillip Brady Hayden Chief Financial Officer A +30,000 deriv. —
2026-02-12 Rebecca R Reed Gen Counsel A +30,000 deriv. —
2026-02-12 John Thomas Vilade Jr Chief Commercial Officer A +250,000 deriv. —
2026-02-06 Michael Nikzad Director M +38,500 —
2026-02-06 John S Hendricks Director A +27,439 deriv. —
2026-02-06 Patrick J. Keeley Director M +43,750 —
2026-02-06 Jonathan Huberman Director M +43,750 —
2026-02-06 Matthew Blank Director M +37,000 —
2026-02-06 Elizabeth Ann Hendricks Director M +38,500 —
2026-02-06 Andrew Hendricks Director M +38,500 —
2026-01-02 Phillip Brady Hayden Chief Financial Officer Sell −17,474 −$65.66K
2025-12-15 Phillip Brady Hayden Chief Financial Officer Sell −2,000 −$9.18K
2025-12-12 Theresa Ellen Cudahy COO and Secretary Sell −5,768 −$28.70K
2025-11-25 Clinton Larry Stinchcomb President and CEO Sell −100,000 −$462.40K
2025-11-24 Theresa Ellen Cudahy COO and Secretary Sell −10,200 −$50.81K
2025-11-24 Jonathan Huberman Director Sell −14,116 −$70.58K
2025-11-24 Clinton Larry Stinchcomb President and CEO Sell −217,752 −$1.03M
2025-11-17 Phillip Brady Hayden Chief Financial Officer Sell −1,343 −$6.04K
2025-11-17 Theresa Ellen Cudahy COO and Secretary Sell −5,553 −$27.65K
2025-11-17 Jonathan Huberman Director Sell −9,291 −$46.45K
2025-11-13 Rebecca R Reed Gen Counsel MIXED +17,364 −$34.89K
2025-11-13 Clinton Larry Stinchcomb President and CEO MIXED +365,978 −$890.08K
2025-11-13 Phillip Brady Hayden Chief Financial Officer MIXED +101,667 —
2025-11-10 Rebecca R Reed Gen Counsel Sell −4,559 −$18.51K
2025-11-10 Phillip Brady Hayden Chief Financial Officer Sell −17,508 −$67.70K
CURI — Current Insider Holders
InsiderRole Shares HeldValue
Clinton Larry Stinchcomb President and CEO 3,021,260 $7.55M
Jonathan Huberman Director 1,398,619 $3.50M
Theresa Ellen Cudahy COO and Secretary 643,749 $1.61M
Michael Nikzad Director 196,000 $490.00K
Patrick J. Keeley Director 188,450 $471.12K
Elizabeth Ann Hendricks Director 172,785 $431.96K
Matthew Blank Director 168,221 $420.55K
Andrew Hendricks Director 163,383 $408.46K
Rebecca R Reed Gen Counsel 68,533 $171.33K
Phillip Brady Hayden Chief Financial Officer 25,000 $62.50K
CURI Insider Trading FAQ
Who are the insiders at CURI?
10 officers, directors and 10%+ beneficial owners currently report holdings in CURI via SEC Form 4.
Are CURI insiders buying or selling?
Across the 38 most recent Form 4 filings for CURI, 5 were open-market purchases (code P) and 14 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is CURI insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent CURI filing is dated 2026-09-17.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the CURI quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.